Publications by authors named "Cory Heilmann"

Claim this Profile
W
Weight reduction and the impact on apnea-hypopnea index: A systematic meta-analysis.
Atul Malhotra, Cory R Heilmann, Kushal K Banerjee, Julia P Dunn, Mathijs C Bunck

Sleep Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning to active-controlled trials to evaluate cardiovascular safety and efficacy of medications for type 2 diabetes.
Darren K McGuire, David D'Alessio, Stephen J Nicholls, Steven E Nissen, Jeffrey S Riesmeyer, Cory R Heilmann

Cardiovasc Diabetol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with the glucagon receptor antagonist LY2409021 increases ambulatory blood pressure in patients with type 2 diabetes.
Christof M Kazda, Juan Frias, Irene Foga, Xuewei Cui, Cristina B Guzman, Cory Heilmann

Diabetes Obes Metab· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crossover design and its application in late-phase diabetes studies.
Tao Wang, James Malone, Haoda Fu, Cory Heilmann, Yongming Qu

J Diabetes· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of different statistical methods analyzing hypoglycemia data using bootstrap simulations.
Honghua Jiang, Xiao Ni, William Huster, Cory Heilmann

J Biopharm Stat· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group.
Fanni Natanegara, Beat Neuenschwander, John W Seaman, Nelson Kinnersley, Cory R Heilmann

Pharm Stat· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis.
David Ohlssen, Karen L Price, H Amy Xia, Hwanhee Hong, Jouni Kerman, Cory R Heilmann

Pharm Stat· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of exenatide on kidney function, adverse events, and clinical end points of kidney disease in type 2 diabetes.
Katherine R Tuttle, Cory Heilmann, Byron J Hoogwerf, Carl Brown, Pamela W Anderson

Am J Kidney Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.
John B Buse, Michael Nauck, Thomas Forst, Wayne H-H Sheu, Sylvia K Shenouda, Cory R Heilmann

Lancet· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes.
Julio Rosenstock, Sylvia K Shenouda, Richard M Bergenstal, John B Buse, Leonard C Glass, Cory R Heilmann

Diabetes Care· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitus.
Jaime A Davidson, Lyndon B Lacaya, Honghua Jiang, Cory R Heilmann, Jamie L Scism-Bacon

Endocr Pract· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis

Ann Intern Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of AIR inhaled insulin compared with subcutaneous insulin in patients having diabetes and asthma: A 12-month, randomized, noninferiority trial.
Ernesto Ang, Mary K Lawrence, Cory R Heilmann, Jeffrey A Ferguson, Janet A Tobian

Diabetes Technol Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of prandial AIR inhaled insulin alone to intensified insulin glargine alone and to AIR insulin plus intensified insulin glargine in patients with type 2 diabetes previously treated with once-daily insulin glargine.
Julio Rosenstock, Freddy G Eliaschewitz, Cory R Heilmann, Douglas B Muchmore, Risa P Hayes

Diabetes Technol Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle.
Jonathan M Cordeiro, Lindsey Greene, Cory Heilmann, Daniel Antzelevitch, Charles Antzelevitch

Am J Physiol Heart Circ Physiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis